The tumor suppressor role of the histone acetyltransferase, KAT2B (also known as PCAF or p300/CBP-associated factor) was previously proposed in breast cancer [79], esophageal squamous cell cancer [80], and gastric carcinoma [81]. This evidence concerns the gene EP300 and breast cancer.